PHIO PHARMACEUTICALS CORP's ticker is PHIOXXXX and the CUSIP is 71880W204. A total of 17 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $135,000 | -30.4% | 792,374 | +12.3% | 0.00% | -50.0% |
| Q3 2019 | $194,000 | -15.3% | 705,353 | +16.9% | 0.00% | 0.0% |
| Q2 2019 | $229,000 | +122.3% | 603,528 | +163.8% | 0.00% | +100.0% |
| Q1 2019 | $103,000 | +90.7% | 228,825 | +39.8% | 0.00% | – |
| Q4 2018 | $54,000 | – | 163,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 155,135 | $51,000 | 0.11% |
| SABBY MANAGEMENT, LLC | 1,575,157 | $520,000 | 0.11% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 10,790 | $4,000 | 0.00% |
| Advisor Group, Inc. | 19 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 65 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SG Americas Securities, LLC | 163,730 | $54,000 | 0.00% |
| MORGAN STANLEY | 5,718 | $2,000 | 0.00% |
| BlackRock Inc. | 1,115 | $0 | 0.00% |
| Citadel Advisors | 19,886 | $7,000 | 0.00% |